EMA Application withdrawn: Rilonacept FGK Representative Service GmbH (rilonacept) — Rilonacept FGK Representative Service GmbH

View source ↗

Summary

EMA has withdrawn the marketing authorization application for rilonacept (Arcalyst) for pericarditis, filed by Rilonacept FGK Representative Service GmbH; the p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pericarditis

Drugs mentioned

• Arcalyst (rilonacept) (rilonacept)

Snippet

Status: Application withdrawn. Therapeutic area: Pericarditis. MAH: Rilonacept FGK Representative Service GmbH. Orphan medicine